← Eichor
Condition: Hyperammonemia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hyperammonemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency
Phase 1/Phase 2 · 12 location(s) · iECURE, Inc. · NCT06255782Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Phase N/A · 1 location(s) · iECURE, Inc. · NCT06805695Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target T
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT07499349An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
Phase N/A · 5 location(s) · RECORDATI GROUP · NCT05040178Optimalisation of the Treatment of Acute Neonatal Hyperammonaemia
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05754372A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase
Phase N/A · 1 location(s) · Mayo Clinic · NCT06600659Systemic Biomarkers of Brain Injury From Hyperammonemia
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04602325
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.